Simone Walter trained in paediatrics before specialising in audiovestibular medicine. She has participated in research into congenital CMV and hearing loss with virology and paediatric infectious diseases supervisors, Professor Paul Griffiths and Professor Mike Sharland, from a London-based CMV research group. She has also worked with the National Deaf Children’s Society, CMV Action, the Ear Foundation and the British Association of Audiovestibular Physicians to help educate on congenital CMV and hearing loss.
Latest Contribution
Early detection pathways for congenital cytomegalovirus for infants referred from the newborn hearing screen
This article discusses requirements for an early congenital cytomegalovirus (cCMV) detection pathway to ensure children do not miss out on the opportunity for timely diagnosis and treatment. The pathways described are currently in use in England and apply to well...
Congenital CMV: investigations and management in the audiology setting
Congenital cytomegalovirus (cCMV) is the only cause of congenital sensorineural hearing loss (SNHL) for which there is a medical treatment available to prevent further hearing loss. Dr Simone Walter discusses cCMV infection, cCMV-related hearing loss, and how to facilitate their...
